Name | Number of supported studies | Average coverage | |
---|---|---|---|
ionocyte | 5 studies | 28% ± 5% | |
epithelial cell | 4 studies | 30% ± 8% | |
ciliated cell | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1004.99 | 180 / 180 | 100% | 4.69 | 429 / 430 |
breast | 100% | 848.47 | 459 / 459 | 100% | 4.87 | 1113 / 1118 |
brain | 100% | 543.93 | 2637 / 2642 | 100% | 4.74 | 703 / 705 |
esophagus | 100% | 594.76 | 1443 / 1445 | 99% | 4.01 | 182 / 183 |
stomach | 100% | 537.31 | 359 / 359 | 99% | 4.27 | 284 / 286 |
prostate | 100% | 851.49 | 245 / 245 | 99% | 5.09 | 498 / 502 |
lung | 99% | 592.14 | 575 / 578 | 100% | 4.39 | 1151 / 1155 |
pancreas | 100% | 744.77 | 328 / 328 | 99% | 3.57 | 176 / 178 |
intestine | 100% | 642.38 | 966 / 966 | 99% | 4.28 | 521 / 527 |
thymus | 100% | 899.88 | 653 / 653 | 99% | 4.56 | 598 / 605 |
skin | 100% | 820.33 | 1809 / 1809 | 98% | 7.32 | 463 / 472 |
bladder | 100% | 870.00 | 21 / 21 | 98% | 3.84 | 492 / 504 |
uterus | 100% | 786.45 | 170 / 170 | 97% | 3.74 | 447 / 459 |
kidney | 100% | 768.78 | 89 / 89 | 97% | 3.86 | 874 / 901 |
adrenal gland | 100% | 1323.91 | 258 / 258 | 96% | 4.08 | 220 / 230 |
liver | 100% | 528.22 | 226 / 226 | 89% | 2.11 | 360 / 406 |
adipose | 100% | 782.54 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 3.55 | 29 / 29 |
spleen | 100% | 701.49 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 3.59 | 45 / 45 |
blood vessel | 100% | 823.76 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 587.12 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 667.28 | 834 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 3.63 | 75 / 80 |
peripheral blood | 43% | 304.59 | 396 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035269 | Biological process | protein O-linked mannosylation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
GO_0120053 | Molecular function | ribitol beta-1,4-xylosyltransferase activity |
Gene name | RXYLT1 |
Protein name | Ribitol xylosyltransferase 1 Ribitol-5-phosphate xylosyltransferase 1 (EC 2.4.2.61) (Transmembrane protein 5) (UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase) |
Synonyms | TMEM5 |
Description | FUNCTION: Acts as a UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase, which catalyzes the transfer of UDP-D-xylose to ribitol 5-phosphate (Rbo5P) to form the Xylbeta1-4Rbo5P linkage on O-mannosyl glycan (Probable). Participates in the biosynthesis of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1), which is required for binding laminin G-like domain-containing extracellular proteins with high affinity (Probable). . |
Accessions | ENST00000690060.1 A0A8I5QJ99 ENST00000537373.6 Q9Y2B1 G3V1K2 ENST00000687087.1 ENST00000685296.1 A0A8I5KWX9 F5GXF8 ENST00000692910.1 ENST00000537982.5 ENST00000693579.1 ENST00000543342.5 ENST00000261234.11 A0A8I5KTH6 |